The serum ferritin concentration is widely used as a measure of body iron stores but is inappropriately raised in liver disease and in chronic inflammatory and malignant diseases. We report finding raised serum ferritin concentrations in patients with Gaucher's disease.
Serum ferritin concentration in Gaucher's disease
The serum ferritin concentration is widely used as a measure of body iron stores but is inappropriately raised in liver disease and in chronic inflammatory and malignant diseases. We report finding raised serum ferritin concentrations in patients with Gaucher's disease.
Patients, methods, and results
We studied seven patients with type I Gaucher's disease. Serum ferritin was estimated by the immunoradiometric assay previously used in this laboratory. The proportion of glycosylated ferritin was estimated by the concanavalin A binding technique. Unsaturated transcobalamin II concentration was measured by radioactive vitamin B,2 binding and Quso G32 separation.' A standard desferrioxamine 24 hour urine excretion test was performed in two patients using an intramuscular dose of 10 mg desferrioxamine/kg body weight. Other haematological and biochemical measurements were by standard techniques. The table lists the clinical, haematological, and biochemical findings. None of the patients had received previous blood transfusions or, so far as we could ascertain, iron therapy.
Six of the seven patients showed raised serum ferritin concentrations. These bore no relation to the sex of the patient, size of the spleen or liver, blood count, extent of bone lesions, serum acid phosphatase activity, serum aspartate transaminase activity, or concentration of serum vitamin B,2 or unsaturated transcobalamin II. The transcobalamin II concentration was raised in all six patients studied. Interestingly, however, the two youngest patients showed the lowest serum ferritin values. The proportion of serum ferritin bound by concanavalin A, measured in five patients, ranged from 38°,, to 55" (within the normal range). The 24 hour urinary iron excretion after intramuscular desferrioxamine was normal in both patients tested (table) .
Comment
Gaucher's disease is an inborn error of metabolism due to deficiency of a lysosomal enzyme, ,!-glucosidase, resulting in accumulation of glucocerebroside in large macrophages throughout the reticuloendothelial system. We found raised serum ferritin concentrations in six of seven patients with type I Gaucher's disease. This could not be attributed to iron overload as the urinary iron excretion after intramuscular desferrioxamine, estimated in two patients (cases 2 and 4) with a 10-fold increase in serum ferritin concentrations, was not increased. Other studies have found raised serum acid phosphatase activities and transcobalamin II concentrations in Gaucher's disease.2 Acid phosphatase is a lysosomal enzyme present in Gaucher's cells and transcobalamin II is synthesised by macrophages.3 Increased iron has been detected within the macrophages in Gaucher's disease.4 The iron is dispersed within the cells as individual micelles of ferritin.5 Probably raised serum ferritin concentrations in patients with Gaucher's disease result from excessive release of ferritin from the large macrophages (Gaucher's cells). Our results suggest that serum ferritin increases with age in Gaucher's disease, but a much larger study would be necessary to prove this. At all events, Gaucher's disease can be added to the list of conditions in which the serum ferritin value may be inappropriately high in relation to body iron stores. 
